用于1型丙型肝炎病毒的新型全口服疗法：向干扰素彻底告别。 - Suppr

Suppr

超能文献

New all-oral HCV therapies for genotype 1: A final good-bye to interferon.

作者信息

Lok Anna S F

机构信息

Division of Gastroenterology and Hepatology University of Michigan Ann Arbor MI.

出版信息

Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):137-140. doi: 10.1002/cld.369. eCollection 2014 Jun.

DOI:10.1002/cld.369

PMID:30992908

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448721/

Abstract

摘要

相似文献

New all-oral HCV therapies for genotype 1: A final good-bye to interferon.用于1型丙型肝炎病毒的新型全口服疗法：向干扰素彻底告别。

Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):137-140. doi: 10.1002/cld.369. eCollection 2014 Jun.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.博赛泼维联合聚乙二醇干扰素/利巴韦林用于重新治疗HIV-HCV合并感染患者的丙型肝炎病毒1型：西班牙BOC HIV-HCV研究的最终结果

Int J Infect Dis. 2016 Dec;53:46-51. doi: 10.1016/j.ijid.2016.10.028. Epub 2016 Nov 1.

Treatment of hepatitis C: a systematic review.丙型肝炎的治疗：系统评价。

JAMA. 2014 Aug 13;312(6):631-40. doi: 10.1001/jama.2014.7085.

Treatment of chronic HCV genotype 1 coinfection.慢性丙型肝炎病毒1型合并感染的治疗。

Curr HIV/AIDS Rep. 2015 Sep;12(3):326-35. doi: 10.1007/s11904-015-0278-4.

Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.4型基因型导致的慢性丙型肝炎HIV感染患者对基于干扰素疗法的反应

Antivir Ther. 2005;10(1):167-70.

The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?初治慢性丙型肝炎基因1型治疗的治愈价值：新型全口服治疗方案对社会而言是否具有高价值？

Liver Int. 2017 May;37(5):662-668. doi: 10.1111/liv.13298. Epub 2016 Nov 29.

Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.儿童慢性丙型肝炎干扰素α治疗效果的研究。

Med Sci Monit. 2000 Sep-Oct;6(5):964-70.

Simeprevir for the treatment of chronic hepatitis C.西美瑞韦用于治疗慢性丙型肝炎。

Expert Opin Pharmacother. 2013 Dec;14(18):2581-9. doi: 10.1517/14656566.2013.850074. Epub 2013 Oct 19.

High sustained virologic response rate after interferon monotherapy in Japanese hepatitis C patients with a low HCV RNA titer and/or HCV genotype 2. A prospective study.

Intervirology. 2004;47(6):328-34. doi: 10.1159/000080876.

[Efficacy of interferon alpha with ribavirin for treatment of chronic Hepatitis C].

Zhonghua Gan Zang Bing Za Zhi. 2011 Sep;19(9):683-5. doi: 10.3760/cma.j.issn.1007-3418.2011.09.012.

引用本文的文献

The new treatments for hepatitis C virus: An advanced practice provider's perspective.

Clin Liver Dis (Hoboken). 2015 Jan 20;4(6):153-155. doi: 10.1002/cld.432. eCollection 2014 Dec.

Enhancing our understanding of current therapies for hepatitis C virus (HCV).加深我们对丙型肝炎病毒（HCV）现有疗法的理解。

Curr HIV/AIDS Rep. 2015 Mar;12(1):68-78. doi: 10.1007/s11904-014-0243-7.

本文引用的文献

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.ABT-450/r-ombitasvir 和 dasabuvir 联合或不联合利巴韦林治疗 HCV。

N Engl J Med. 2014 May 22;370(21):1983-92. doi: 10.1056/NEJMoa1402338. Epub 2014 May 4.

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。

N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.来迪派韦索磷布韦片治疗既往治疗的 HCV 基因 1 型感染。

N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.ABT-450/r-ombitasvir 和 dasabuvir 联合利巴韦林治疗肝硬化合并丙型肝炎。

N Engl J Med. 2014 May 22;370(21):1973-82. doi: 10.1056/NEJMoa1402869. Epub 2014 Apr 11.

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.ABT-450/r-ombitasvir 和利巴韦林联合治疗 HCV。

N Engl J Med. 2014 Apr 24;370(17):1594-603. doi: 10.1056/NEJMoa1315722. Epub 2014 Apr 10.

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.聚乙二醇干扰素α-2a 联合利巴韦林治疗慢性丙型肝炎

N Engl J Med. 2014 May 15;370(20):1879-88. doi: 10.1056/NEJMoa1402355. Epub 2014 Apr 10.

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.ABT-450/r-ombitasvir 和 dasabuvir 联合利巴韦林治疗 HCV。

N Engl J Med. 2014 Apr 24;370(17):1604-14. doi: 10.1056/NEJMoa1401561. Epub 2014 Apr 10.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.索磷布韦联合利巴韦林治疗治疗特征不佳的丙型肝炎 1 型患者：一项随机临床试验。

JAMA. 2013 Aug 28;310(8):804-11. doi: 10.1001/jama.2013.109309.

Sofosbuvir for previously untreated chronic hepatitis C infection.索磷布韦片治疗未经治疗的慢性丙型肝炎感染。

N Engl J Med. 2013 May 16;368(20):1878-87. doi: 10.1056/NEJMoa1214853. Epub 2013 Apr 23.

Preliminary study of two antiviral agents for hepatitis C genotype 1.慢性丙型肝炎病毒感染的抗病毒治疗进展

N Engl J Med. 2012 Jan 19;366(3):216-24. doi: 10.1056/NEJMoa1104430.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验